Talampanel for Amyotrophic Lateral Sclerosis (ALS) (ALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00696332
Recruitment Status : Completed
First Posted : June 12, 2008
Last Update Posted : October 21, 2011
Information provided by (Responsible Party):
Teva Pharmaceutical Industries

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : April 2010
  Study Completion Date : May 2010
  Certification/Extension First Submitted : August 16, 2011